Form 4: INSMED Chief Legal Officer Sells Shares Under Pre-Arranged Trading Plan
Insider Transaction Report
INSMED's Chief Legal Officer, Michael Alexander Smith, sold 1,879 shares of common stock for $73.5 per share on June 5, 2025, as part of a pre-arranged 10b5-1 trading plan.
Summary
- Michael Alexander Smith, Chief Legal Officer of INSMED Inc. (INSM), reported a sale of company common stock.
- The transaction involved the disposition of 1,879 shares of common stock.
- The shares were sold at a price of $73.5 per share.
- The sale occurred on June 5, 2025.
- Following this transaction, Mr. Smith beneficially owns 67,718 shares of INSMED common stock.
- This transaction was conducted pursuant to a Rule 10b5-1 trading plan, which was adopted by Mr. Smith on February 27, 2025.
Sentiment
Score: 4
Explanation: The sale of shares by a Chief Legal Officer, while conducted under a pre-arranged 10b5-1 trading plan, represents a reduction in insider ownership. While 10b5-1 plans are common for liquidity and diversification, any insider selling can be perceived as a neutral to slightly negative signal by the market, depending on the context and magnitude relative to total holdings.
Positives
- The transaction was executed under a Rule 10b5-1 trading plan, adopted on February 27, 2025, indicating a pre-scheduled sale not based on immediate, non-public information.
Negatives
- A Chief Legal Officer sold 1,879 shares of company common stock, which, while routine under a 10b5-1 plan, represents a reduction in insider ownership.
Future Outlook
NA
Industry Context
This Form 4 filing is specific to INSMED Inc. and its Chief Legal Officer, Michael Alexander Smith. It does not provide broader industry context or trends.
Stakeholder Impact
- Shareholders: May view the insider sale as a neutral to slightly negative signal, although the pre-arranged 10b5-1 plan mitigates concerns about opportunistic selling.
Key Dates
| Date | Description |
|---|---|
| 02/27/2025 | Date the Reporting Person adopted the 10b5-1 trading plan. |
| 06/05/2025 | Date of transaction (sale of common stock). |
| 06/06/2025 | Date the Form 4 was signed by the Reporting Person. |
Keywords
INSMED, INSM, Form 4, insider trading, stock sale, Michael Alexander Smith, Chief Legal Officer, 10b5-1 plan, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.